What does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?
Dominic Tyer, Editorial director
FREE | VIEW NOW
Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.
Dominic Tyer, Editorial director
FREE | VIEW NOW
In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.
Dominic Tyer, Editorial director
FREE | VIEW NOW
As the number of doctors willing to see pharmaceutical sales representatives in person declines how digital tools can help with access, reach and rep effectiveness?
Dominic Tyer, Editorial director
FREE | VIEW NOW
There is growing momentum and recognition among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research, including development and validation of Clinical Outcome Assessments, and participation of patients in clinical trials.
Dominic Tyer, Editorial director
FREE | VIEW NOW
Advances in KOL intelligence are delivering richer insights into clinical landscapes than ever before, better enabling pharma to meet the challenges of an increasingly competitive and complex environment for KOL engagement.
Dominic Tyer, Editorial director
FREE | VIEW NOW
There are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a lot of talk about the former, but not so much about the latter.
Dominic Tyer, Editorial director
FREE | VIEW NOW
As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient care?
Dominic Tyer, Editorial director
FREE | VIEW NOW
Reach is one thing, trust is another. Digital channels may well be are growing in reach, but recent research from Cello Health Insight found that when it comes to trust, doctors value face-to-face interactions with peers, KOLs and sales reps as sources of information with the greatest influence on their decision to prescribe. The digital space presents big opportunities, yet it remains to some extent the new frontier for pharma marketers, who have a big responsibility to understand it and get it right.
Dominic Tyer, Editorial director
FREE | VIEW NOW
'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP and board member for Greenwich CCG.
Dominic Tyer, Editorial director
FREE | VIEW NOW
'UK payer perspectives: the market access value paradox' will feature Ryan Wooller, director of market access and service innovation at Quintiles and Dr Junaid Bajwa, a GP and board member for Greenwich CCG.
Dominic Tyer, Editorial director
FREE | VIEW NOW
Living with any chronic health condition can be demanding, but rare diseases bring a unique set of challenges for patients.
Chaired by Clare Bates, Commercial Director, PMGroup
FREE | VIEW NOW
Join Professor Rob Horne and the Spoonful of Sugar (SoS) team on Wednesday 28th May at 14:30 GMT as they discuss the essential components of effective, next generation patient support.
Chaired by Dominic Tyer, Editorial director
FREE | VIEW NOW
Despite the vast progress in treatments delivered by Pharma, across multiple therapeutic areas, suboptimal patient outcomes in the real world setting remains a major concern for all stakeholders. Payers and empowered patients alike are demanding better clinical and economic outcomes that demonstrate value ‘beyond the pill’.
Chaired by Dominic Tyer, Editorial director
FREE | VIEW NOW
This free webinar will provide a deep dive into the Digital Futures 2014 survey, conducted by PMGroup in association with Havas Lynx.
Chaired by Dominic Tyer, Editorial director
FREE | VIEW NOW
For this 22 April webinar we bring together a panel of experts in hepatitis C to discuss this important topic, including a healthcare funder, a pharma medical director and an adherence researcher.
Chaired by Dominic Tyer, Editorial Director, PMGroup
FREE | VIEW NOW
Digital channels continue to be a key focus for 2014, but as pharma continues to look ahead to a digital future is there more we can be doing to enhance the impact of digital strategies?
Chaired by Dominic Tyer, Editorial Director, PMGroup
FREE | VIEW NOW
Ways of driving field team performance - Free Webinar
Chaired by Dominic Tyer, Editorial Director, PMGroup
FREE | VIEW NOW
This webinar will feature three case studies of good practice in diabetes care
Chaired by Louise Bellamy, Quality in Care Programme Manager
FREE | VIEW NOW
This webinar will feature four case studies of good practice in diabetes care
Chaired by Dominic Tyer, Editorial director
FREE | VIEW NOW
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...